mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.34 |
0.02 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
0.31 |
0.02 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |